Drug-Coated Balloon After Intravascular Lithotripsy
In calcified coronary lesions, DCB after IVL demonstrates excellent efficacy and safety, achieving high technical success with low device-dependent adverse event rates.
Authors
- Valeria Paradies
- Bimmer E.P.M. Claessen (ORCID: https://orcid.org/0000-0002-1703-7921)
- J. Wouter Jukema (ORCID: https://orcid.org/0000-0002-3246-8359)
- Hany Girgis (ORCID: https://orcid.org/0000-0002-5985-7880)
- Joëlle Kefer (ORCID: https://orcid.org/0000-0001-8338-908X)
- Alessandro Mandurino‐Mirizzi (ORCID: https://orcid.org/0000-0003-4162-5384)
- Gianluca Mincione
- Aukelien C. Dimitriu‐Leen (ORCID: https://orcid.org/0000-0001-9131-9903)
- Tessel Vossenberg (ORCID: https://orcid.org/0000-0003-1122-2429)
- Brian O. Bingen (ORCID: https://orcid.org/0000-0002-4986-8623)
- Frank van der Kley (ORCID: https://orcid.org/0000-0003-4521-8698)
- Federico Oliveri (ORCID: https://orcid.org/0000-0001-5946-0827)
- Akshay A S Phagu
- Ibtihal Al Amri (ORCID: https://orcid.org/0000-0002-2772-7029)
- José M. Montero-Cabezas
Institutions
- Cliniques Universitaires Saint-Luc (BE)
- Radboud University Nijmegen (NL)
- Leiden University Medical Center (NL)
- Radboud University Medical Center (NL)
- Medisch Centrum Haaglanden (NL)
- Netherlands Heart Institute (NL)
- Maasstad Ziekenhuis (NL)
- Amsterdam University Medical Centers (NL)
- Ospedale Vito Fazzi (IT)
- Jeroen Bosch Ziekenhuis (NL)
- IRCCS Humanitas Research Hospital (IT)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-10-25
- DOI
- https://doi.org/10.1016/j.jacadv.2025.102250
- Primary Topic
- Cerebrovascular and Carotid Artery Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00